Showing 1 - 8 results of 8 for search 'Huiping Qiang', query time: 0.04s Refine Results
  1. 1
    467 A real-world retrospective study of immunotherapy in NSCLC patients with KRAS mutation

    467 A real-world retrospective study of immunotherapy in NSCLC patients with KRAS mutation by Hua Zhong, Huiping Qiang

    Published 2023-11-01
    Article
  2. 2
    Mining GEO and TCGA Database for Immune Microenvironment of Lung Squamous Cell Carcinoma Patients With or Without Chemotherapy

    Mining GEO and TCGA Database for Immune Microenvironment of Lung Squamous Cell Carcinoma Patients With or Without Chemotherapy by Huiping Qiang, Jiaqi Li, Qing Chang, Yinchen Shen, Jialin Qian, Tianqing Chu

    Published 2022-02-01
    Get full text
    Article
  3. 3
    Comparison of the efficacy and safety in the treatment strategies between chemotherapy combined with antiangiogenic and with immune checkpoint inhibitors in advanced non-small cell lung cancer patients with negative PD-L1 expression: A network meta-analysis

    Comparison of the efficacy and safety in the treatment strategies between chemotherapy combined with antiangiogenic and with immune checkpoint inhibitors in advanced non-small cell... by Jiaqi Li, Yingjie Chen, Fan Hu, Huiping Qiang, Qing Chang, Jialin Qian, Yinchen Shen, Yong Cai, Tianqing Chu

    Published 2022-11-01
    Get full text
    Article
  4. 4
    Epidermal Growth Factor Receptor Mutation Status and Response to Tyrosine Kinase Inhibitors in Advanced Chinese Female Lung Squamous Cell Carcinoma: A Retrospective Study

    Epidermal Growth Factor Receptor Mutation Status and Response to Tyrosine Kinase Inhibitors in Advanced Chinese Female Lung Squamous Cell Carcinoma: A Retrospective Study by Qing Chang, Huiping Qiang, Jialin Qian, Yuqiong Lei, Jiahuan Lu, Hui Feng, Yiming Zhao, Baohui Han, Yanwei Zhang, Tianqing Chu

    Published 2021-04-01
    Get full text
    Article
  5. 5
    Anti-angiogenic therapy or immunotherapy? A real-world study of patients with advanced non-small cell lung cancer with EGFR/HER2 exon 20 insertion mutations

    Anti-angiogenic therapy or immunotherapy? A real-world study of patients with advanced non-small cell lung cancer with EGFR/HER2 exon 20 insertion mutations by Jiaqi Li, Mengqing Xie, Ruiying Zhao, Huiping Qiang, Qing Chang, Jialin Qian, Haijiao Lu, Yinchen Shen, Yuchen Han, Chunxia Su, Tianqing Chu

    Published 2024-03-01
    Get full text
    Article
  6. 6
    Efficacy of first-line chemotherapy combined with immunotherapy or anti-angiogenic therapy in advanced KRAS-mutant non-small cell lung cancer

    Efficacy of first-line chemotherapy combined with immunotherapy or anti-angiogenic therapy in advanced KRAS-mutant non-small cell lung cancer by Huiping Qiang, Yue Wang, Yao Zhang, Jingwen Li, Lincheng Zhang, Huawei Du, Xuxinyi Ling, Shuhui Cao, Yan Zhou, Runbo Zhong, Hua Zhong

    Published 2025-03-01
    Get full text
    Article
  7. 7
    Effective low-dose Anlotinib induces long-term tumor vascular normalization and improves anti-PD-1 therapy

    Effective low-dose Anlotinib induces long-term tumor vascular normalization and improves anti-PD-1 therapy by Peng Fan, Peng Fan, Huiping Qiang, Zhenhua Liu, Qi Zhao, Ying Wang, Tingkun Liu, Xuan Wang, Tianqing Chu, Yuhui Huang, Wei Xu, Songbing Qin

    Published 2022-08-01
    Get full text
    Article
  8. 8
    Dynamic alterations of ctDNA associate with the therapeutic outcome in the advanced non‐small cell lung cancer patients who received sintilimab plus anlotinib regime as 1st line therapy

    Dynamic alterations of ctDNA associate with the therapeutic outcome in the advanced non‐small cell lung cancer patients who received sintilimab plus anlotinib regime as 1st line th... by Tianqing Chu, Jie Yuan, Jun Lu, Wei Nie, Runbo Zhong, Bo Zhang, Wei Zhang, Chunlei Shi, Jialin Qian, Yanwei Zhang, Xueyan Zhang, Jiajun Teng, Zhiqiang Gao, Yuqing Lou, Jiaqi Li, Huiping Qiang, Chao Zhang, Jin Li, Xuefeng Xia, Hua Zhong, Baohui Han

    Published 2023-06-01
    Get full text
    Article

Search Tools: